Thus the inducible CYP2D6 model was used to perform a B cell epitope mapping at several defined times after initiation of the disease (i.e., Ad-2D6 infection) in order to reveal to which CYP2D6 epitope antibodies are generated first. Here, CYP2D6 is linked to Alzheimer disease.